Artificial intelligence (AI)-powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study Meeting Abstract

  

Authors:	Dacic, S.; Travis, W. D.; Giltnane, J. M.; Abel, J.; Kos, F.; Hilz, S.; Hennek, S.; Fujimoto, J.; Sholl, L. M.; Khalil, F.; Ritter, J.; D'Apuzzo, M.; Lee, J. M.; Rusch, V. W.; Carbone, D. P.; Nicholas, A.; Johnson, A.; Schulze, K.; Kris, M. G.; Wistuba, I. I.
Abstract Title:	Artificial intelligence (AI)-powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study
Meeting Title:	2021 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	39
Issue:	15 Suppl.
Meeting Dates:	2021 Jun 4-8
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2021-05-20
Language:	English
ACCESSION:	WOS:000708120600008
DOI:	10.1200/JCO.2021.39.15_suppl.106
PROVIDER:	wos
Notes:	Meeting Abstract: 106 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/191220